Top compounds associated with response to DRD5


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib CCLE pan-cancer AAC 0.00029 1
mRNA 681640 GDSC1000 pan-cancer AAC -0.0002 1
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 6.9e-05 1
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC 0.00021 1
mRNA palmostatin B CTRPv2 pan-cancer AAC -6.7e-05 1
mRNA PL-DI CTRPv2 pan-cancer AAC -6.1e-06 1
Download CSV